Dry Eye Syndrome Market 2022-2027
LONDON, UK, November 24, 2022 / EINPresswire. com / — The global dry eye syndrome market size reached USD 5, 465. 0 million in 2021, according to a new report by GlobalData Plc. Dry eye symptoms (DES), also known as keratoconjunctivitis sicca (KCS), is a multi-factorial disease of the eye characterized by dryness, decreased tear production, or increased tear film evaporation. Patients with DES experience symptoms of discomfort, such as visual disturbance and tear film instability. DES is more common in women and particularly in postmenopausal women. Sex hormones are known to play a significant role within ocular surface homeostasis, plus studies are investigating the mechanisms by which disturbances in ocular surface homeostasis may result in DES.
View Report Outlook at: https://www.globaldata.com/store/report/dry-eye-syndrome-market-analysis/
Anti-androgen therapy, Sjögren’s syndrome, and premature ovarian failure also may increase the risk for DES, as these conditions are associated with androgen deficiency. The research on dry eye syndrome is significant due in order to the rising frequency of its occurrence, multiple risk factors linked with the disease, and problems in disease treatment. According to reports published by the United Kingdom Statistics Authority, inside 2019, nearly 21, 900 people were registered as eye related. This rising prevalence of ophthalmological diseases and their related complications directly promotes the growth of this market.
The Dry out Eye Symptoms Market outlook report along with detailed segment analysis will be available with Global Data Now! Make a Purchase Right Here!
The particular pharmaceutical sector has prioritized the development of new medicine for the treatment of dry eyes. Even though dry eye is the most common eye illness, it is not life-threatening, and its symptoms are not severe, there is a limited supply of effective treatment medicines. Dozens of businesses have a wide range associated with novel therapy possibilities within their pipelines, but the particular disease’s overall complexity makes it difficult to manage. Only a few medications have been approved so far for the remedying of dried out eye sickness, but the potential for advancement in this field is usually enormous. As a result, many new possible remedies are usually being developed or placed in the pharmaceutical pipeline, promising greater outcomes and fewer side effects.
Learn about the Dried out Eye Syndrome Market Dynamics by Viewing the Report Sample Right Here!
Dry Vision Syndrome Market Report Highlights
• The global dry eye syndrome market is projected to witness a CAGR of four. 8% from 2021 to 2027, reaching a value of $7. 2 million. The market is set to gain thrust during the forecast period on account of the increasing aging population.
• In 2021, the particular anti-inflammatory products segment from the dry vision syndrome marketplace is estimated at US$ 2, 285. 0 mil in 2021 and is definitely forecast in order to reach US$ 3, 091. 0 million by 2027, growing at a CAGR associated with 5. 2%.
• The dry eye syndrome market’s eye drops and solutions segment can be estimated in $2, 602. 1 mil in 2021 and is certainly expected to grow to $3, 524. 4 million simply by 2027, growing in a CAGR of five. 2%.
• The hospital pharmacy section of the dry eye symptoms market is estimated from $1, 815. 2 million in 2021 and is expected to grow up to $2, 405. 5 million by 2027, developing at a CAGR of 4. 9%.
• The market has witnessed development in attention care centers to handle the rising burden of ophthalmological disorders, which will boost the market growth during the particular forecast period.
• North America closely followed by Europe captured over 39. 9% from the general dry eyesight syndrome share in 2021. Vendors in these regions are launching various items, thereby accelerating market development.
• The dry eyes syndrome market key players analyzed as part of this report are Novartis AG, AbbVie Inc, plus Sun Pharmaceuticals Ltd., among others
Unlock additional market dynamics impacting the Dry Attention Syndrome marketplace growth simply by Requesting a Sample PDF
GlobalData Plc has segmented the Dry Eye Symptoms market statement by Product, Therapeutic Area, and region:
Dry Eyesight Syndrome Products Outlook (Revenue, USD Million, 2020-2027)
• Anti-inflammatory Drugs
• Artificial Tears
• Punctal Plugs
• Secretagogues
Dry Eyes Syndrome Dosage Form Outlook (Revenue, UNITED STATES DOLLAR Million, 2020-2027)
• Eye Drops and Solutions
• Gels plus Ointments
• Capsules and Tablets
Dry Eye Syndrome Distribution Channel Perspective (Revenue, USD Million, 2020-2027)
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
Dry Eye Syndrome Regional View (Revenue, UNITED STATES DOLLAR Million, 2020-2027)
• North America
• US
• Canada
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Rest associated with Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• ROW
Get Segment-wise Insights and Regional Opportunities at: https://www.globaldata.com/store/talk-to-us/?report=3314297
Related Reports
• https://www.globaldata.com/store/report/glaucoma-competitive-landscape-to-2026/
About us
GlobalData is the leading data, analytics, plus insights provider in the world’s largest industries. In an increasingly fast-moving, complex, and uncertain world, it has never been harder for organizations and decision-makers to predict plus navigate the future. GlobalData’s mission is in order to help our clients to decode the particular future and profit through faster, more informed decisions. As a leading information services company, thousands of clients rely on us with regard to trusted, timely, and actionable intelligence. Our solutions are designed in order to provide a daily edge to professionals within corporations, financial institutions, professional services, plus government agencies.
Media Contacts
Mark Jephcott
GlobalData Plc
+44 20 7936 6400
mark. [email protected] possuindo
Visit us on social media:
Twitter
LinkedIn
